title: Highlights from CROI 2014 on experimental HIV drugs.
authors.affiliation: Division of Clinical Virology, INIBIC-Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
authors.forename: Eva
authors.initials: E
authors.lastname: Poveda
authors.affiliation: Division of Clinical Virology, INIBIC-Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
authors.forename: José D
authors.initials: JD
authors.lastname: Pedreira
mesh_terms: D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D024882:Drug Resistance, Viral / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D020128:Inhibitory Concentration 50; D011728:Pyridones / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*; D019562:Viral Load / Q000187:drug effects*; D054659:Diketopiperazines
chemical_list: D019380:Anti-HIV Agents; D011728:Pyridones; D014230:Triazoles; C000592662:doravirine; C584914:cabotegravir; D054659:Diketopiperazines